Scinovex
articleTop 10% cited

The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity

Journal of Pharmacology and Experimental Therapeutics · 2003 · Vol. 306(1) · pp. 287–300
Bryan A. WardJ. Christopher GorskiDavid R. JonesStephen D. HallDavid A. FlockhartZeruesenay Desta
HIV/AIDS drug development and treatmentHIV Research and TreatmentHIV-related health complications and treatmentsEfavirenzCYP2B6ChemistryHydroxylationSubstrate (aquarium)MicrosomeCytochrome P450KineticsMetabolismCYP1A2

MeSH terms

AlkynesAryl Hydrocarbon HydroxylasesBiotransformationCatalysisCyclopropanesHIVHumansMicrosomes, LiverOxazinesOxidoreductases, N-DemethylatingRecombinant ProteinsHIV InfectionsAnti-HIV AgentsBenzoxazinesCytochrome P-450 CYP2B6
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.